| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.556 | 0.025 | 0.611 | Aldehyde oxidase inhibitor | 0.611 0.017 CID_127009 | CID_127009 | |
| 0.532 | 0.004 | 0.532 | 5 Hydroxytryptamine uptake stimulant | 0.428 0.01 CID_127009 | ||
| 0.556 | 0.066 | 0.556 | Antiinflammatory | 0.547 0.069 CID_127009 | ||
| 0.502 | 0.032 | 0.523 | Cholesterol antagonist | 0.523 0.029 CID_127009 | CID_127009 | |
| 0.503 | 0.04 | 0.503 | Antibacterial | 0.42 0.068 CID_127009 | ||
| 0.504 | 0.058 | 0.504 | Caspase 9 stimulant | 0.474 0.071 CID_127009 | ||
| 0.514 | 0.07 | 0.514 | Apoptosis agonist | 0.387 0.12 CID_127009 | ||
| 0.478 | 0.048 | 0.478 | Transcription factor NF kappa B inhibitor | 0.381 0.068 CID_127009 | ||
| 0.455 | 0.035 | 0.455 | 5 Hydroxytryptamine release stimulant | 0.301 0.069 CID_127009 | ||
| 0.414 | 0.027 | 0.414 | Hypoxia-inducible factor 1 alpha inhibitor | 0.288 0.072 CID_127009 | ||
| 0.389 | 0.013 | 0.389 | Platelet adhesion inhibitor | 0.16 0.096 CID_127009 | ||
| 0.405 | 0.034 | 0.405 | Antioxidant | 0.306 0.059 CID_127009 | ||
| 0.414 | 0.058 | 0.414 | Immunosuppressant | 0.411 0.058 CID_127009 | ||
| 0.397 | 0.048 | 0.397 | Streptokinase A inhibitor | 0.191 0.139 CID_127009 | ||
| 0.375 | 0.026 | 0.375 | Sodium/bile acid cotransporter inhibitor | 0.372 0.028 CID_127009 | ||
| 0.374 | 0.027 | 0.374 | Angiogenesis stimulant | 0.373 0.027 CID_127009 | ||
| 0.422 | 0.079 | 0.593 | Cyclophilin D inhibitor | 0.593 0.029 CID_127009 | CID_127009 | |
| 0.361 | 0.03 | 0.361 | Transcription factor STAT inhibitor | 0.264 0.078 CID_127009 | ||
| 0.353 | 0.03 | 0.355 | DNA synthesis inhibitor | 0.355 0.029 CID_127009 | CID_127009 | |
| 0.336 | 0.015 | 0.336 | Interferon gamma antagonist | 0.319 0.017 CID_127009 | ||
| 0.375 | 0.056 | 0.375 | Antithrombotic | 0.308 0.083 CID_127009 | ||
| 0.343 | 0.035 | 0.343 | Transcription factor STAT3 inhibitor | 0.254 0.08 CID_127009 | ||
| 0.379 | 0.071 | 0.379 | GABA C receptor rho-3 antagonist | 0.249 0.155 CID_127009 | ||
| 0.372 | 0.077 | 0.58 | Antiobesity | 0.58 0.023 CID_127009 | CID_127009 | |
| 0.289 | 0.019 | 0.309 | Phospholipase C inhibitor | 0.309 0.017 CID_127009 | CID_127009 | |
| 0.314 | 0.048 | 0.314 | Platelet antagonist | 0.161 0.133 CID_127009 | ||
| 0.295 | 0.032 | 0.295 | RNA-directed DNA polymerase inhibitor | 0.259 0.044 CID_127009 | ||
| 0.355 | 0.097 | 0.355 | 15-Lipoxygenase inhibitor | |||
| 0.259 | 0.003 | 0.259 | Glucagon-like peptide 1 receptor antagonist | 0.063 0.008 CID_127009 | ||
| 0.281 | 0.025 | 0.281 | Lipocortins synthesis antagonist | 0.263 0.03 CID_127009 | ||
| 0.26 | 0.005 | 0.26 | Vanilloid agonist | 0.175 0.008 CID_127009 | ||
| 0.273 | 0.021 | 0.273 | Topoisomerase II inhibitor | 0.224 0.029 CID_127009 | ||
| 0.27 | 0.028 | 0.27 | Neurotrophic factor enhancer | 0.254 0.036 CID_127009 | ||
| 0.267 | 0.027 | 0.267 | Protein-tyrosine phosphatase inhibitor | 0.205 0.045 CID_127009 | ||
| 0.277 | 0.046 | 0.277 | Tyrosine 3 hydroxylase inhibitor | 0.241 0.077 CID_127009 | ||
| 0.234 | 0.01 | 0.239 | Arachidonic acid antagonist | 0.239 0.008 CID_127009 | CID_127009 | |
| 0.3 | 0.078 | 0.3 | Caspase 3 stimulant | 0.254 0.109 CID_127009 | ||
| 0.278 | 0.058 | 0.278 | Free radical scavenger | 0.202 0.096 CID_127009 | ||
| 0.234 | 0.018 | 0.234 | Cystathionine beta-synthase inhibitor | 0.186 0.028 CID_127009 | ||
| 0.304 | 0.088 | 0.304 | Calcium channel activator | 0.251 0.146 CID_127009 | ||
| 0.357 | 0.142 | 0.357 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.272 0.253 CID_127009 | ||
| 0.218 | 0.008 | 0.218 | Vanilloid 1 agonist | 0.19 0.015 CID_127009 | ||
| 0.329 | 0.121 | 0.329 | Analgesic | |||
| 0.255 | 0.048 | 0.266 | Anesthetic general | 0.266 0.043 CID_127009 | CID_127009 | |
| 0.204 | 0.004 | 0.204 | Fatty acid synthase inhibitor | 0.106 0.009 CID_127009 | ||
| 0.203 | 0.006 | 0.203 | CDC25A inhibitor | 0.178 0.009 CID_127009 | ||
| 0.248 | 0.052 | 0.248 | Nitric oxide antagonist | 0.221 0.06 CID_127009 | ||
| 0.228 | 0.032 | 0.299 | Lipid peroxidase inhibitor | 0.299 0.019 CID_127009 | CID_127009 | |
| 0.223 | 0.035 | 0.223 | Antipruritic | 0.143 0.103 CID_127009 | ||
| 0.242 | 0.057 | 0.274 | Peptidyltransferase inhibitor | 0.274 0.036 CID_127009 | CID_127009 | |
| 0.194 | 0.013 | 0.194 | HIV-1 integrase (Overall Integration) inhibitor | 0.128 0.035 CID_127009 | ||
| 0.23 | 0.05 | 0.23 | Hepatoprotectant | 0.198 0.066 CID_127009 | ||
| 0.19 | 0.011 | 0.19 | Sphingosine 1-phosphate receptor 4 antagonist | 0.155 0.029 CID_127009 | ||
| 0.198 | 0.026 | 0.198 | Adenylate cyclase inhibitor | 0.148 0.047 CID_127009 | ||
| 0.173 | 0.005 | 0.173 | Glycine receptor agonist | 0.134 0.009 CID_127009 | ||
| 0.221 | 0.057 | 0.221 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.195 0.077 CID_127009 | ||
| 0.182 | 0.018 | 0.182 | Topoisomerase II alpha inhibitor | 0.16 0.021 CID_127009 | ||
| 0.185 | 0.022 | 0.185 | Adenylate cyclase stimulant | 0.176 0.029 CID_127009 | ||
| 0.205 | 0.045 | 0.223 | Succinate dehydrogenase inhibitor | 0.223 0.034 CID_127009 | CID_127009 | |
| 0.216 | 0.057 | 0.216 | Sigma receptor agonist | 0.132 0.1 CID_127009 | ||
| 0.171 | 0.012 | 0.171 | Ca2+-transporting ATPase inhibitor | 0.168 0.014 CID_127009 | ||
| 0.189 | 0.032 | 0.189 | Protein-tyrosine phosphatase 1B inhibitor | 0.137 0.051 CID_127009 | ||
| 0.161 | 0.005 | 0.161 | Glycine receptor antagonist | 0.103 0.03 CID_127009 | ||
| 0.179 | 0.025 | 0.179 | Antineoplastic antibiotic | 0.165 0.028 CID_127009 | ||
| 0.285 | 0.132 | 0.285 | Histamine release inhibitor | 0.285 0.132 CID_127009 | ||
| 0.162 | 0.009 | 0.162 | T cell inhibitor | 0.124 0.013 CID_127009 | ||
| 0.164 | 0.011 | 0.164 | Aromatase inhibitor | 0.071 0.033 CID_127009 | ||
| 0.173 | 0.024 | 0.173 | Pregnane X receptor agonist | 0.154 0.045 CID_127009 | ||
| 0.16 | 0.013 | 0.16 | Anabolic | 0.146 0.02 CID_127009 | ||
| 0.179 | 0.033 | 0.181 | Cholesterol synthesis inhibitor | 0.181 0.032 CID_127009 | CID_127009 | |
| 0.301 | 0.157 | 0.301 | Calcium channel L-type activator | 0.301 0.157 CID_127009 | ||
| 0.189 | 0.046 | 0.189 | Melanin inhibitor | 0.178 0.053 CID_127009 | ||
| 0.238 | 0.094 | 0.238 | Gastrin inhibitor | 0.214 0.128 CID_127009 | ||
| 0.189 | 0.046 | 0.189 | Protein kinase stimulant | 0.187 0.047 CID_127009 | ||
| 0.18 | 0.038 | 0.18 | Monophenol monooxygenase inhibitor | 0.156 0.045 CID_127009 | ||
| 0.238 | 0.097 | 0.347 | Spasmolytic | 0.347 0.054 CID_127009 | CID_127009 | |
| 0.147 | 0.006 | 0.147 | Estradiol 17 beta-dehydrogenase inhibitor | 0.057 0.021 CID_127009 | ||
| 0.24 | 0.107 | 0.24 | Lipoxygenase inhibitor | |||
| 0.155 | 0.022 | 0.157 | Creatine kinase inhibitor | 0.157 0.021 CID_127009 | CID_127009 | |
| 0.157 | 0.027 | 0.157 | TRPA1 agonist | 0.115 0.064 CID_127009 | ||
| 0.233 | 0.103 | 0.233 | Immunostimulant | 0.209 0.115 CID_127009 | ||
| 0.154 | 0.026 | 0.254 | AMP-activated protein kinase stimulant | 0.254 0.006 CID_127009 | CID_127009 | |
| 0.155 | 0.027 | 0.155 | GABA C receptor antagonist | 0.117 0.056 CID_127009 | ||
| 0.166 | 0.039 | 0.179 | Aldehyde dehydrogenase inhibitor | 0.179 0.034 CID_127009 | CID_127009 | |
| 0.295 | 0.17 | 0.299 | 5 Hydroxytryptamine release inhibitor | 0.299 0.166 CID_127009 | CID_127009 | |
| 0.171 | 0.046 | 0.171 | CF transmembrane conductance regulator agonist | 0.132 0.113 CID_127009 | ||
| 0.14 | 0.027 | 0.14 | Prolactin inhibitor | 0.104 0.051 CID_127009 | ||
| 0.123 | 0.01 | 0.123 | CDC25B inhibitor | 0.102 0.015 CID_127009 | ||
| 0.16 | 0.05 | 0.16 | Neuropeptide Y1 antagonist | |||
| 0.145 | 0.036 | 0.145 | GABA C receptor agonist | 0.095 0.072 CID_127009 | ||
| 0.143 | 0.035 | 0.143 | Photosensitizer | 0.134 0.043 CID_127009 | ||
| 0.165 | 0.059 | 0.165 | NOS3 expression enhancer | 0.132 0.094 CID_127009 | ||
| 0.151 | 0.047 | 0.151 | Cyclooxygenase 3 inhibitor | 0.148 0.05 CID_127009 | ||
| 0.153 | 0.05 | 0.158 | Toll-Like receptor 2 antagonist | 0.158 0.047 CID_127009 | CID_127009 | |
| 0.134 | 0.031 | 0.134 | Electron transport complex I inhibitor | 0.121 0.046 CID_127009 | ||
| 0.141 | 0.038 | 0.141 | CC chemokine 6 receptor antagonist | 0.129 0.076 CID_127009 | ||
| 0.133 | 0.034 | 0.133 | Estrogen antagonist | 0.125 0.046 CID_127009 | ||
| 0.101 | 0.004 | 0.101 | Pregnane X receptor antagonist | 0.092 0.004 CID_127009 | ||
| 0.106 | 0.009 | 0.106 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.099 0.01 CID_127009 | ||
| 0.14 | 0.043 | 0.14 | Microtubule formation inhibitor | 0.127 0.053 CID_127009 | ||
| 0.116 | 0.019 | 0.116 | Na+ K+ transporting ATPase inhibitor | 0.114 0.02 CID_127009 | ||
| 0.141 | 0.045 | 0.141 | Topoisomerase I inhibitor | 0.095 0.074 CID_127009 | ||
| 0.124 | 0.028 | 0.124 | Estrogen receptor beta antagonist | 0.113 0.042 CID_127009 | ||
| 0.148 | 0.055 | 0.148 | Farnesoid X receptor antagonist | 0.143 0.061 CID_127009 | ||
| 0.157 | 0.067 | 0.157 | Heat shock protein 90 antagonist | |||
| 0.101 | 0.011 | 0.101 | Heat shock protein 90 beta antagonist | 0.054 0.052 CID_127009 | ||
| 0.093 | 0.003 | 0.093 | Protein 30S ribosomal subunit inhibitor | 0.081 0.004 CID_127009 | ||
| 0.202 | 0.115 | 0.202 | Superoxide dismutase inhibitor | 0.198 0.119 CID_127009 | ||
| 0.137 | 0.049 | 0.137 | Papain-like protease (SARS coronavirus) inhibitor | 0.117 0.091 CID_127009 | ||
| 0.104 | 0.02 | 0.108 | Estrogen-related receptor beta agonist | 0.108 0.017 CID_127009 | CID_127009 | |
| 0.107 | 0.024 | 0.107 | Estrogen receptor alpha antagonist | 0.092 0.033 CID_127009 | ||
| 0.157 | 0.074 | 0.157 | Peroxidase inhibitor | 0.14 0.084 CID_127009 | ||
| 0.155 | 0.073 | 0.155 | Hexokinase inhibitor | 0.138 0.093 CID_127009 | ||
| 0.086 | 0.005 | 0.086 | Cholesterol esterase inhibitor | 0.048 0.034 CID_127009 | ||
| 0.123 | 0.042 | 0.123 | DOPA decarboxylase inhibitor | 0.111 0.057 CID_127009 | ||
| 0.11 | 0.031 | 0.11 | CYP2A6 inhibitor | |||
| 0.088 | 0.009 | 0.088 | Kinesin antagonist | |||
| 0.088 | 0.009 | 0.088 | Kinesin-like protein 1 inhibitor | |||
| 0.157 | 0.08 | 0.157 | Heat shock protein 90 alpha antagonist | |||
| 0.092 | 0.016 | 0.092 | Protease activated receptor 1 antagonist | |||
| 0.09 | 0.017 | 0.09 | Glutamate (mGluR7) antagonist | 0.063 0.058 CID_127009 | ||
| 0.098 | 0.027 | 0.098 | HIV-1 integrase (3'-Processing) inhibitor | 0.073 0.037 CID_127009 | ||
| 0.081 | 0.01 | 0.081 | Dihydroorotate oxidase inhibitor | 0.064 0.024 CID_127009 | ||
| 0.172 | 0.104 | 0.172 | Insulin sensitizer | 0.172 0.104 CID_127009 | ||
| 0.22 | 0.157 | 0.245 | Interleukin 2 agonist | 0.245 0.125 CID_127009 | CID_127009 | |
| 0.139 | 0.076 | 0.139 | Cell wall synthesis inhibitor | |||
| 0.104 | 0.041 | 0.104 | Bile acid receptor antagonist | 0.098 0.053 CID_127009 | ||
| 0.167 | 0.106 | 0.167 | Antimitotic | |||
| 0.139 | 0.081 | 0.139 | Sphingosine 1-phosphate receptor 5 antagonist | 0.137 0.085 CID_127009 | ||
| 0.074 | 0.017 | 0.074 | Diacylglycerol O-acyltransferase inhibitor | 0.055 0.03 CID_127009 | ||
| 0.132 | 0.075 | 0.132 | Bone formation stimulant | 0.131 0.076 CID_127009 | ||
| 0.129 | 0.073 | 0.129 | Interleukin 4 antagonist | 0.125 0.078 CID_127009 | ||
| 0.153 | 0.097 | 0.153 | ATPase inhibitor | |||
| 0.063 | 0.008 | 0.063 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.038 0.017 CID_127009 | ||
| 0.079 | 0.025 | 0.079 | Glutamate (mGluR6) antagonist | 0.074 0.032 CID_127009 | ||
| 0.09 | 0.037 | 0.09 | Ca(v)3.1 blocker | 0.078 0.067 CID_127009 | ||
| 0.094 | 0.041 | 0.094 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.079 0.052 CID_127009 | ||
| 0.086 | 0.034 | 0.086 | HIV-1 integrase inhibitor | 0.065 0.056 CID_127009 | ||
| 0.124 | 0.074 | 0.146 | Alpha-N-acetylglucosaminidase inhibitor | 0.146 0.057 CID_127009 | CID_127009 | |
| 0.069 | 0.018 | 0.069 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.076 | 0.026 | 0.083 | Androgen agonist | 0.083 0.022 CID_127009 | CID_127009 | |
| 0.101 | 0.052 | 0.101 | Falcipain 2 inhibitor | |||
| 0.102 | 0.052 | 0.102 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.087 0.069 CID_127009 | ||
| 0.223 | 0.174 | 0.223 | Toll-Like receptor 7 agonist | |||
| 0.089 | 0.04 | 0.089 | CC chemokine 5 receptor agonist | |||
| 0.102 | 0.053 | 0.102 | Falcipain inhibitor | |||
| 0.107 | 0.06 | 0.107 | Beta glucuronidase inhibitor | |||
| 0.055 | 0.009 | 0.055 | Retinoid X receptor antagonist | 0.042 0.02 CID_127009 | ||
| 0.055 | 0.009 | 0.055 | Delayed rectifier potassium channel blocker | 0.04 0.022 CID_127009 | ||
| 0.21 | 0.165 | 0.21 | Vasodilator, peripheral | 0.203 0.172 CID_127009 | ||
| 0.095 | 0.05 | 0.095 | Glutamate release inhibitor | |||
| 0.086 | 0.041 | 0.098 | Keratolytic | 0.098 0.031 CID_127009 | CID_127009 | |
| 0.109 | 0.065 | 0.112 | Mucolytic | 0.112 0.063 CID_127009 | CID_127009 | |
| 0.07 | 0.026 | 0.07 | Heme oxygenase stimulant | 0.061 0.043 CID_127009 | ||
| 0.136 | 0.094 | 0.136 | GABA C receptor rho-2 antagonist | |||
| 0.129 | 0.087 | 0.129 | Mannose-6-phosphate isomerase inhibitor | 0.117 0.107 CID_127009 | ||
| 0.068 | 0.027 | 0.068 | Estrogen agonist | 0.047 0.038 CID_127009 | ||
| 0.066 | 0.027 | 0.067 | Lipocortins synthesis agonist | 0.067 0.024 CID_127009 | CID_127009 | |
| 0.059 | 0.02 | 0.059 | Aldosterone antagonist | 0.05 0.029 CID_127009 | ||
| 0.179 | 0.141 | 0.179 | Interleukin agonist | 0.166 0.152 CID_127009 | ||
| 0.046 | 0.009 | 0.046 | Retinoid X alpha receptor antagonist | 0.036 0.02 CID_127009 | ||
| 0.05 | 0.013 | 0.05 | RNA-directed RNA polymerase inhibitor | |||
| 0.07 | 0.033 | 0.07 | TRPA1 antagonist | |||
| 0.053 | 0.017 | 0.053 | 5-Alpha-reductase inhibitor | 0.037 0.026 CID_127009 | ||
| 0.045 | 0.01 | 0.045 | ATP citrate lysase inhibitor | 0.031 0.023 CID_127009 | ||
| 0.036 | 0.001 | 0.036 | Antibiotic Tetracycline-like | 0.031 0.002 CID_127009 | ||
| 0.062 | 0.027 | 0.062 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.051 | 0.017 | 0.051 | Dopamine D5 agonist | |||
| 0.09 | 0.056 | 0.09 | Ornithine decarboxylase inhibitor | 0.086 0.06 CID_127009 | ||
| 0.089 | 0.056 | 0.103 | Androgen antagonist | 0.103 0.044 CID_127009 | CID_127009 | |
| 0.051 | 0.019 | 0.051 | GABA B receptor antagonist | |||
| 0.044 | 0.012 | 0.044 | HCV NS5B polymerase inhibitor | |||
| 0.081 | 0.049 | 0.081 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.043 | 0.011 | 0.043 | Cholesterol ester transfer protein antagonist | 0.041 0.012 CID_127009 | ||
| 0.091 | 0.06 | 0.091 | Thioredoxin inhibitor | |||
| 0.215 | 0.184 | 0.215 | Toll-Like receptor agonist | |||
| 0.088 | 0.056 | 0.088 | NMDA receptor antagonist | |||
| 0.047 | 0.016 | 0.047 | Retinoid X alpha receptor agonist | 0.037 0.022 CID_127009 | ||
| 0.056 | 0.026 | 0.056 | CD45 antagonist | 0.049 0.038 CID_127009 | ||
| 0.088 | 0.058 | 0.094 | Interleukin 5 antagonist | 0.094 0.048 CID_127009 | CID_127009 | |
| 0.047 | 0.018 | 0.049 | GABA uptake inhibitor | 0.049 0.016 CID_127009 | CID_127009 | |
| 0.036 | 0.008 | 0.036 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.205 | 0.177 | 0.215 | Vasodilator, coronary | 0.215 0.168 CID_127009 | CID_127009 | |
| 0.069 | 0.042 | 0.081 | Cannabinoid receptor agonist | 0.081 0.035 CID_127009 | CID_127009 | |
| 0.171 | 0.144 | 0.171 | DNA damaging | |||
| 0.036 | 0.01 | 0.042 | Prostaglandin EP2 agonist | 0.042 0.008 CID_127009 | CID_127009 | |
| 0.064 | 0.039 | 0.064 | HIV-1 integrase (Strand Transfer) inhibitor | |||
| 0.061 | 0.036 | 0.061 | Bcl-xL inhibitor | |||
| 0.146 | 0.12 | 0.146 | Psychostimulant | |||
| 0.051 | 0.026 | 0.051 | Adenylate cyclase 1 inhibitor | |||
| 0.032 | 0.007 | 0.032 | Vanilloid 2 agonist | 0.025 0.018 CID_127009 | ||
| 0.033 | 0.008 | 0.033 | Hedgehog signaling activator | 0.029 0.016 CID_127009 | ||
| 0.033 | 0.009 | 0.033 | Retinoid X gamma receptor antagonist | 0.027 0.018 CID_127009 | ||
| 0.179 | 0.155 | 0.179 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.059 | 0.035 | 0.059 | Human rhinovirus A protease inhibitor | |||
| 0.064 | 0.041 | 0.064 | Protease activated receptor antagonist | |||
| 0.075 | 0.052 | 0.075 | Vanilloid 4 agonist | |||
| 0.043 | 0.021 | 0.043 | Retinoid X receptor agonist | 0.032 0.028 CID_127009 | ||
| 0.044 | 0.022 | 0.044 | Kainate receptor agonist | |||
| 0.027 | 0.005 | 0.027 | Retinoid X beta receptor antagonist | 0.021 0.012 CID_127009 | ||
| 0.075 | 0.053 | 0.075 | GABA aminotransferase inhibitor | |||
| 0.055 | 0.034 | 0.062 | Cannabinoid CB2 receptor antagonist | 0.062 0.028 CID_127009 | CID_127009 | |
| 0.056 | 0.035 | 0.056 | GABA receptor antagonist | 0.053 0.04 CID_127009 | ||
| 0.036 | 0.015 | 0.036 | Diacylglycerol O-acyltransferase 1 inhibitor | |||
| 0.095 | 0.075 | 0.097 | Expectorant | 0.097 0.072 CID_127009 | CID_127009 | |
| 0.041 | 0.022 | 0.041 | Progesterone antagonist | 0.038 0.023 CID_127009 | ||
| 0.031 | 0.011 | 0.031 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.047 | 0.029 | 0.047 | Purinergic P2Y antagonist | |||
| 0.046 | 0.028 | 0.046 | NMDA receptor subunit 3B antagonist | |||
| 0.17 | 0.152 | 0.17 | Nitric-oxide synthase stimulant | |||
| 0.04 | 0.021 | 0.04 | Estrogen receptor beta agonist | |||
| 0.061 | 0.043 | 0.061 | NMDA 2C receptor antagonist | |||
| 0.103 | 0.085 | 0.103 | Alkylator | 0.101 0.088 CID_127009 | ||
| 0.035 | 0.017 | 0.035 | Glucagon receptor antagonist | |||
| 0.059 | 0.041 | 0.062 | Sphingosine kinase inhibitor | 0.062 0.035 CID_127009 | CID_127009 | |
| 0.09 | 0.073 | 0.099 | UDP-glucose 4-epimerase inhibitor | 0.099 0.062 CID_127009 | CID_127009 | |
| 0.035 | 0.018 | 0.035 | RNA-directed RNA polymerase stimulant | 0.027 0.023 CID_127009 | ||
| 0.056 | 0.039 | 0.069 | Alcohol oxidase inhibitor | 0.069 0.029 CID_127009 | CID_127009 | |
| 0.106 | 0.09 | 0.106 | Transcription factor STAT6 inhibitor | |||
| 0.036 | 0.02 | 0.036 | Tubulin agonist | |||
| 0.039 | 0.023 | 0.039 | Glucose-6-phosphate dehydrogenase inhibitor | 0.038 0.024 CID_127009 | ||
| 0.054 | 0.038 | 0.054 | Cannabinoid CB2 receptor agonist | 0.053 0.038 CID_127009 | ||
| 0.041 | 0.025 | 0.041 | Membrane dipeptidase inhibitor | |||
| 0.077 | 0.063 | 0.077 | Opioid kappa receptor antagonist | |||
| 0.098 | 0.084 | 0.098 | Anesthetic local | |||
| 0.155 | 0.141 | 0.155 | Antiamyloidogenic | |||
| 0.088 | 0.075 | 0.088 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.14 | 0.127 | 0.14 | Neurotensin receptor agonist | |||
| 0.124 | 0.111 | 0.126 | Phospholipase A2 inhibitor | 0.126 0.108 CID_127009 | CID_127009 | |
| 0.046 | 0.033 | 0.046 | Potassium channel Kv1.3 blocker | |||
| 0.033 | 0.02 | 0.033 | Glutamate (mGluR3) agonist | 0.032 0.022 CID_127009 | ||
| 0.051 | 0.038 | 0.051 | Aconitate hydratase inhibitor | |||
| 0.051 | 0.039 | 0.051 | GABA A receptor antagonist | |||
| 0.043 | 0.031 | 0.043 | Glutamate (mGluR group III) antagonist | |||
| 0.019 | 0.008 | 0.019 | NMDA receptor phencyclidine site antagonist | |||
| 0.02 | 0.009 | 0.02 | Nicotinic acid receptor 1 antagonist | |||
| 0.021 | 0.01 | 0.021 | Antibiotic Anthracycline-like | 0.021 0.009 CID_127009 | ||
| 0.054 | 0.043 | 0.054 | Beta tubulin antagonist | |||
| 0.072 | 0.062 | 0.072 | GABA B receptor agonist | |||
| 0.018 | 0.008 | 0.018 | Thromboxane A2 agonist | 0.017 0.009 CID_127009 | ||
| 0.033 | 0.024 | 0.033 | Estrogen receptor alpha agonist | |||
| 0.037 | 0.029 | 0.037 | Vanilloid 3 antagonist | |||
| 0.075 | 0.067 | 0.075 | Neuropeptide Y antagonist | |||
| 0.118 | 0.112 | 0.118 | Acetylcholine M1 receptor antagonist | |||
| 0.074 | 0.068 | 0.074 | MAP kinase kinase 7 inhibitor | 0.073 0.071 CID_127009 | ||
| 0.022 | 0.017 | 0.023 | Prostaglandin F2 alpha agonist | 0.023 0.014 CID_127009 | CID_127009 | |
| 0.021 | 0.016 | 0.021 | Estrone sulfatase inhibitor | |||
| 0.139 | 0.134 | 0.139 | Catenin beta inhibitor | |||
| 0.065 | 0.06 | 0.065 | Epoxide hydrolase inhibitor | |||
| 0.025 | 0.021 | 0.025 | Nicotinic acid receptor 2 antagonist | |||
| 0.083 | 0.079 | 0.083 | ABCA1 expression enhancer | |||
| 0.016 | 0.014 | 0.016 | Telomerase stimulant | |||
| 0.028 | 0.026 | 0.033 | Prostaglandin agonist | 0.033 0.019 CID_127009 | CID_127009 | |
| 0.076 | 0.074 | 0.076 | Thioredoxin reductase inhibitor | |||
| 0.006 | 0.004 | 0.006 | Transcortin receptor antagonist | 0.006 0.004 CID_127009 | ||
| 0.033 | 0.032 | 0.034 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.034 0.031 CID_127009 | CID_127009 | |
| 0.011 | 0.01 | 0.011 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | |||
| 0.033 | 0.033 | 0.038 | Farnesoid X receptor agonist | 0.038 0.026 CID_127009 | CID_127009 | |
| 0.037 | 0.038 | 0.04 | Sphingosine kinase 1 inhibitor | 0.04 0.032 CID_127009 | CID_127009 | |
| 0.142 | 0.145 | 0.184 | Hypolipemic | 0.184 0.106 CID_127009 | CID_127009 | |
| 0.07 | 0.1 | 0.08 | Triose-phosphate isomerase inhibitor | 0.08 0.075 CID_127009 | CID_127009 | |
| 0.019 | 0.176 | 0.054 | Maillard reaction inhibitor | 0.054 0.039 CID_127009 | CID_127009 | |
| 0.009 | 0.311 | 0.046 | Purinergic P2X3 antagonist | 0.046 0.013 CID_127009 | CID_127009 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |